NATALEE trial
New thread to discuss the NATALEE trial (double blinded study evaluating use of CDK4 inhibitor in hormone positive early BC) Feel free to post if you are likely to enrol/have already enrolled :) ...
Forum Discussion
@sister there’s a lot on line and being conducted at FMC.Here’s a bit about it .
NATALEE with ribociclib
A study of endocrine therapy with ribociclib (CDK4/6 inhibitor) in patients with high-risk early-stage hormone receptor positive breast cancer following surgery.
- Requirements: patients with high risk early-stage breast cancer which is hormone receptor positive, HER2 receptor negative and have undergone breast surgery, within 12 months of commencing adjuvant endocrine therapy.